SPRB

NASDAQ open

Spruce Biosciences

38.76 USD
▼-1.73-4.27%
盘后 45.89 0.00%
2026-11-20
市值
$109.21M
市盈率
—
EPS
-33.82
股息率
—
52 周区间
38.06 – 115.00
成交量
84.94K
Beta
3.54
目标价
147.44
52W 低 38.0652W 高 115.00
价格走势

公司简介

Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, including anhedonia, weight alterations, and altered sle...